C
Christopher B. Newgard
Researcher at Duke University
Publications - 483
Citations - 55811
Christopher B. Newgard is an academic researcher from Duke University. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 111, co-authored 460 publications receiving 49018 citations. Previous affiliations of Christopher B. Newgard include Durham University & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study
Anjali Gupta,Veeral M. Saraiya,April Deveaux,Taofik Oyekunle,Klarissa D. Jackson,Omolola Salako,Adetola Daramola,Allison Hall,Olusegun I. Alatise,Gabriel O. Ogun,Adewale Stephen Adeniyi,Omobolaji O. Ayandipo,Thomas Olajide,Olalekan Olasehinde,Olukayode Arowolo,Adewale O. Adisa,Oludolapo O Afuwape,Aralola Adepeju Olusanya,Aderemi Adegoke,Trygve O. Tollefsbol,Donna K. Arnett,Michael J. Muehlbauer,Christopher B. Newgard,Samuel Ajayi,Yemi Raheem Raji,T O Olanrewaju,Charlotte Osafo,Ifeoma Ulasi,Adanze Onyenonachi Asinobi,Cheryl Winkler,David T. Burke,Fatiu A Arogundade,Ivy Ekem,Jacob Plange-Rhule,Manmak Mamven,Michael Mate-Kole,Olukemi K. Amodu,Richard S. Cooper,Sampson Antwi,Adebowale Adeyemo,Titilayo O. Ilori,Victoria Adabayeri,Alexander K. Nyarko,Anita Ghansah,Ernestine Kubi Amos-Abanyie,Priscilla Abena Akyaw,Paul L. Kimmel,Babatunde L. Salako,Rulan S. Parekh,Bamidele O. Tayo,Rasheed Gbadegesin,Michael Boehnke,Robert Lyons,Frank C. Brosius,Daniel A Clauw,Chijioke Adindu,Clement O. Bewaji,Elliot Koranteng Tannor,Perditer Okyere,C N Ijoma,Nicki Tiffin,Junaid Gamiedien,Friedhelm Hildebrandt,Charles Odenigbo,Nonyelun Jisieike-Onuigbo,Ifeoma A Modebe,Aliyu Abdu,PN Obiagwu,OI Okoye,Adaobi U Solarin,Toyin Amira,Christopher Imokhuede Esezobor,M. A. Makusidi,Santosh L. Saraf,Victor R. Gordeuk,Gloria Ashuntangtang,Georgette Guenkam,Folefack Kazi,Olanrewaju T. Adedoyin,Mignon McCullough,Peter Nourse,Uchenwa Linus Okafor,Emmanuel Ademola Anigilaje,Patrick Ikpebe,Tola Odetunde,Ngozi R Mbanefo,Wasiu A Olowu,Paulina Tindana,Olubenga Awobusuyi,Olugbenga Ogedegbe,Opeyemi A. Olabisi,Karl Skorecki,Ademola Olabisi J. Adebowale,Matthias Kretzler,Jeffrey B. Hodgin,Dwomoa Adu,Akinlolu O. Ojo,Vincent Boima,Tomi Akinyemiju +98 more
TL;DR: In this paper , the association of lipid biomarkers (total cholesterol, high-density lipoprotein (HDL), low-density lipid (LDL), and triglycerides) with increased risk of breast cancer in African women was examined.
Reversing adipocyte differentiation: Implications for treatment of obesity (leptinypost-adipocyteydedifferentiationylipogenesisyoxidation)
TL;DR: It is reported here that the hyperleptinemia depletes adipocyte fat while profoundly down-regulating lipogenic enzymes and their transcription factor, peroxisome proliferator-activated receptor (PPAR)gamma in epididymal fat, which suggests a strategy for the treatment of obesity by alteration of the adipocyte phenotype.
Patent
Gene products that regulate glucose response in cells
TL;DR: In this article, the identification of numerous genes, both known and unknown, that play an important role in the ability of cell to respond to glucose stimulation under physiologic conditions is described.
Journal ArticleDOI
Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study
Anjali Gupta,Veeral M. Saraiya,April Deveaux,Taofik Oyekunle,Klarissa D. Jackson,Omolola Salako,Adetola Daramola,Allison Hall,Olusegun I. Alatise,Gabriel O. Ogun,Adewale Stephen Adeniyi,Omobolaji O. Ayandipo,Thomas Olajide,Olalekan Olasehinde,Olukayode Arowolo,Adewale O. Adisa,Oludolapo O Afuwape,Aralola Adepeju Olusanya,Aderemi Adegoke,Trygve O. Tollefsbol,Donna K. Arnett,Michael J. Muehlbauer,Christopher B. Newgard,Tomi Akinyemiju +23 more
TL;DR: In this article , the association of lipid biomarkers (total cholesterol, high-density lipoprotein (HDL), low-density lipid (LDL), and triglycerides) with increased risk of breast cancer in African women was examined.
Journal ArticleDOI
Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: analysis of the MEND study
Munshid Falih Wadi,Tomi Akinyemiju,Taofik Oyekunle,Omolola Salako,Anjali Gupta,Olusegun I. Alatise,Gabriel O. Ogun,Adewale Adeniyi,April Deveaux,Allison Hall,Omobolaji O. Ayandipo,Thomas Olajide,Olalekan Olasehinde,Olukayode Arowolo,Adewale O. Adisa,Oludolapo Afuwape,Aralola Olusanya,Aderemi Adegoke,Trygve O. Tollefsbol,Donna K. Arnett,Michael J. Muehlbauer,Christopher B. Newgard,Adetola Daramola,Adetola Daramola +23 more
TL;DR: In this article, the association between metabolic syndrome and breast cancer was investigated in a case-control study of Nigerian women, where multinomial logistic regression models were used to evaluate each molecular subtype (Luminal A, Luminal B, HER2-enriched and triple negative or TNBC).